Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
ADAMA Ltd. (000553.SZ)
Jingzhou, CN
ADAMA Ltd., along with its affiliated companies, operates primarily in the agricultural sector as a crop protection enterprise. Its operations are divided into two key segments: Crop Protection (Agro), and Intermediates and Ingredients. Within its Crop Protection division, ADAMA develops, manufactures, and markets essential products such as herbicides, insecticides, and fungicides. These are designed to assist farmers in safeguarding their crops against threats like weeds, insects, and plant diseases. The Intermediates and Ingredients segment supplies a diverse range of chemical compounds, including various food additives, Lycopan (an anti-oxidation agent), synthetic aromatic substances, dietary supplements, food colorants, and components for enhancing texture and flavor. It also provides ingredients for food fortification and other specialized chemicals. Beyond these core offerings, the company manufactures fragrance products utilized across the perfume, cosmetics, body care, and detergent industries. It also delivers industrial goods, formulations, flame retardants, non-agricultural items, and comprehensive consumer and professional solutions. ADAMA maintains a significant global presence, conducting business across Europe, North America, Latin America, the Asia Pacific region, India, the Middle East, and Africa. The company, established in 1945 and headquartered in Jingzhou, Hubei, was formerly known as Hubei Sanonda Co., Ltd. It adopted its current name, ADAMA Ltd., in December 2018 and operates as a subsidiary of Syngenta Group Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.94% | -5.73% | +11.32% | +17.80% | +5.20% | +29.20% | +9.94% | -19.27% | -21.16% | -33.83% | +103.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | -1 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%-1.8% Q1'26: +0.5% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+64.0% ★ Q1'26: +269.2% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+1.1% Q1'26: -17.4% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+1.3% Q1'26: +7.0% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+1.4% Q1'26: +6.1% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×5.55× Q1'26: 9.19× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
19.89B
est: 4.12B (+382.3%)
|
22.07B
est: 4.89B (+351.6%)
|
26.87B
est: 26.14B (+2.8%)
|
27.56B
est: 26.49B (+4.1%)
|
28.44B
est: 28.64B (-0.7%)
|
31.04B
est: 31.00B (+0.1%)
|
37.38B
est: 35.91B (+4.1%)
|
32.78B
est: 32.42B (+1.1%)
|
29.49B
est: 29.01B (+1.6%)
|
28.94B
est: 29.88B (-3.1%)
|
30.63B
30.63B – 30.63B
+2.5% YoY
|
32.72B
32.72B – 32.72B
+6.8% YoY
|
35.27B
35.27B – 35.27B
+7.8% YoY
|
| EBITDA |
2.93B
est: 441.11M (+564.6%)
|
3.57B
est: 522.72M (+582.0%)
|
4.47B
est: 2.80B (+60.0%)
|
4.19B
est: 2.83B (+48.0%)
|
3.80B
est: 3.06B (+24.1%)
|
3.61B
est: 3.32B (+8.8%)
|
4.63B
est: 3.84B (+20.6%)
|
2.51B
est: 3.47B (-27.6%)
|
2.49B
est: 2.83B (-12.0%)
|
2.49B
est: 2.91B (-14.5%)
|
2.98B
2.98B – 2.98B
+2.5% YoY
|
3.19B
3.19B – 3.19B
+6.8% YoY
|
3.44B
3.44B – 3.44B
+7.8% YoY
|
| EBIT |
1.87B
est: 189.98M (+883.7%)
|
1.84B
est: 225.13M (+717.9%)
|
2.42B
est: 1.20B (+101.2%)
|
2.02B
est: 1.22B (+65.3%)
|
1.71B
est: 1.32B (+29.4%)
|
1.83B
est: 1.43B (+28.1%)
|
2.67B
est: 1.65B (+61.4%)
|
621.64M
est: 1.49B (-58.4%)
|
617.90M
est: 1.07B (-42.0%)
|
385.34M
est: 1.10B (-64.9%)
|
1.12B
1.12B – 1.12B
+2.5% YoY
|
1.20B
1.20B – 1.20B
+6.8% YoY
|
1.30B
1.30B – 1.30B
+7.8% YoY
|
| Net Income |
714.88M
est: 2.45B (-70.8%)
|
369.08M
est: 3.08B (-88.0%)
|
2.45B
est: 2.60B (-5.8%)
|
277.04M
est: 1.20B (-76.9%)
|
352.75M
est: 220.99M (+59.6%)
|
157.40M
est: 139.79M (+12.6%)
|
609.39M
est: 955.22M (-36.2%)
|
-1.61B
est: -1.38B (-16.5%)
|
-2.90B
est: -2.25B (-29.0%)
|
-1.05B
est: -512.56M (-104.0%)
|
512.56M
512.56M – 512.56M
+200.0% YoY
|
733.89M
733.89M – 733.89M
+43.2% YoY
|
1.07B
1.07B – 1.07B
+46.0% YoY
|
| SGA |
4.14B
est: 718.24M (+475.8%)
|
5.11B
est: 851.11M (+500.8%)
|
5.70B
est: 4.55B (+25.2%)
|
6.19B
est: 4.61B (+34.3%)
|
5.99B
est: 4.99B (+20.1%)
|
5.11B
est: 5.40B (-5.4%)
|
5.80B
est: 6.25B (-7.2%)
|
5.24B
est: 5.65B (-7.2%)
|
5.32B
est: 4.40B (+21.0%)
|
2.83B
est: 4.53B (-37.5%)
|
4.64B
4.64B – 4.64B
+2.5% YoY
|
4.96B
4.96B – 4.96B
+6.8% YoY
|
5.35B
5.35B – 5.35B
+7.8% YoY
|
| EPS |
0.24
est: 1.05 (-77.3%)
|
0.22
est: 1.32 (-83.3%)
|
1.00
est: 1.12 (-10.3%)
|
0.11
est: 0.52 (-78.0%)
|
0.15
est: 0.09 (+59.6%)
|
0.07
est: 0.06 (+12.7%)
|
0.26
est: 0.41 (-36.2%)
|
-0.69
est: -0.59 (-16.6%)
|
-1.25
est: -0.97 (-29.4%)
|
-0.45
est: -0.22 (-104.5%)
|
0.22
0.22 – 0.22
+200.0% YoY
|
0.32
0.32 – 0.32
+43.2% YoY
|
0.46
0.46 – 0.46
+46.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P China ETF GXC | 0.03% | 118.5K | 0.59% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 26.3K | 0.46% |
| 3 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.00% | 4.0K | 0.58% |
| 4 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 16.5K | 0.26% |
| 5 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 7.3K | 0.48% |
| 6 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 812.5K | 0.06% |
| 7 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 41.0K | 0.39% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 2.2K | 0.44% |
| 9 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.00% | 19.7K | 0.17% |
| 10 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.00% | 19.7K | 0.17% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bruce Morris | Executive Vice President of AI Production | — | — |
| Efrat Nagar | Executive Vice President & Chief Financial Officer | — | female |
| Elad Shabtai | Executive Vice President of Formulation Supply | — | male |
| Eric Dereudre | Executive Vice President & Chief Commercial Officer | — | male |
| Florian Wagner | Executive Vice President of Portfolio & Innovation | — | male |
| Gaël Ali Hili | Chief Executive Officer & President | — | male |
| Gigi-Anne Hoh | Chief Legal Advisor to the Chief Executive Officer & Management (external) | — | female |
| Keren Yonayov | Comptroller of the Group | — | — |
| Zhi Guo | Secretary of the Board of Directors | — | male |
| Zhujun Wang | Securities Affairs Representative & China Investor Relations Manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 000553.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
